Adherium Ltd

ASX:ADRDA (Australia)  
A$ 0.02 (+11.11%) Jun 21
At Loss
P/B:
1.53
Market Cap:
A$ 14.60M ($ 9.76M)
Enterprise V:
A$ 11.48M ($ 7.67M)
Volume:
406.28K
Avg Vol (2M):
3.93M
Trade In:
Volume:
406.28K
At Loss
Avg Vol (2M):
3.93M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Adherium Ltd ( ASX:ADRDA ) from 2015 to Jun 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Adherium stock (ASX:ADRDA) PE ratio as of Jun 22 2024 is 0. More Details

Adherium Ltd (ASX:ADRDA) PE Ratio (TTM) Chart

To

Adherium Ltd (ASX:ADRDA) PE Ratio (TTM) Historical Data

Total 1302
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Adherium PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-22 At Loss 2024-04-22 At Loss
2024-06-21 At Loss 2024-04-19 At Loss
2024-06-20 At Loss 2024-04-18 At Loss
2024-06-19 At Loss 2024-04-17 At Loss
2024-06-18 At Loss 2024-04-16 At Loss
2024-06-17 At Loss 2024-04-15 At Loss
2024-06-14 At Loss 2024-04-12 At Loss
2024-06-13 At Loss 2024-04-11 At Loss
2024-06-12 At Loss 2024-04-10 At Loss
2024-06-11 At Loss 2024-04-09 At Loss
2024-06-10 At Loss 2024-04-08 At Loss
2024-06-07 At Loss 2024-04-05 At Loss
2024-06-06 At Loss 2024-04-04 At Loss
2024-06-05 At Loss 2024-04-03 At Loss
2024-06-04 At Loss 2024-04-02 At Loss
2024-06-03 At Loss 2024-04-01 At Loss
2024-05-31 At Loss 2024-03-29 At Loss
2024-05-30 At Loss 2024-03-28 At Loss
2024-05-29 At Loss 2024-03-27 At Loss
2024-05-28 At Loss 2024-03-26 At Loss
2024-05-27 At Loss 2024-03-25 At Loss
2024-05-24 At Loss 2024-03-22 At Loss
2024-05-23 At Loss 2024-03-21 At Loss
2024-05-22 At Loss 2024-03-20 At Loss
2024-05-21 At Loss 2024-03-19 At Loss
2024-05-20 At Loss 2024-03-18 At Loss
2024-05-17 At Loss 2024-03-15 At Loss
2024-05-16 At Loss 2024-03-14 At Loss
2024-05-15 At Loss 2024-03-13 At Loss
2024-05-14 At Loss 2024-03-12 At Loss
2024-05-13 At Loss 2024-03-11 At Loss
2024-05-10 At Loss 2024-03-08 At Loss
2024-05-09 At Loss 2024-03-07 At Loss
2024-05-08 At Loss 2024-03-06 At Loss
2024-05-07 At Loss 2024-03-05 At Loss
2024-05-06 At Loss 2024-03-04 At Loss
2024-05-03 At Loss 2024-03-01 At Loss
2024-05-02 At Loss 2024-02-29 At Loss
2024-05-01 At Loss 2024-02-28 At Loss
2024-04-30 At Loss 2024-02-27 At Loss
2024-04-29 At Loss 2024-02-26 At Loss
2024-04-26 At Loss 2024-02-23 At Loss
2024-04-25 At Loss 2024-02-22 At Loss
2024-04-24 At Loss 2024-02-21 At Loss
2024-04-23 At Loss 2024-02-20 At Loss

Adherium Ltd (ASX:ADRDA) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that address sub-optimal medication use and improve health outcomes in chronic disease. Geographically, it derives a majority of its revenue from Europe and also has a presence in New Zealand and Australia; North America, and Asia.